Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hemophilia a patients monitored for 5 years on esperoct

NCT ID NCT04574076

ENROLLING_BY_INVITATION Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows about 60 males with hemophilia A who are already using Esperoct to prevent bleeds. Researchers will track side effects and how well the medicine controls bleeding over 5-7 years. Participants continue their normal treatment and clinic visits, with no extra procedures required.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HAEMOPHILIA A

Contacts and locations

Locations

  • "Laiko" General Hospital of Athens

    Athens, 11527, Greece

  • "Laiko" General Hospital of Athens

    Athens, GR-11527, Greece

  • A.O.U Città Salute Scienza Torino

    Torino, 10126, Italy

  • AKH - Klin. Abt. f. Haematologie u. Haemostaseologie

    Vienna, 1090, Austria

  • Aghia Sophia Childrens' Hospital

    Athens, GR-11527, Greece

  • Azienda Ospedaliera-Universitaria Parma

    Parma, 43126, Italy

  • Centro Hospitalar Lisboa Norte-HSM

    Lisbon, 1649-035, Portugal

  • FN Brno odd. hematologie

    Brno, 625 00, Czechia

  • FN HK - IV. Interni hematologicka klinika

    Hradec Králové, 500 05, Czechia

  • Hospital Regional Universitario de Málaga

    Málaga, 29009, Spain

  • Hospital of LUHS "Kauno Klinikos"

    Kaunas, LT-50161, Lithuania

  • KBC Zagreb, Rebro, Hemofilija centar

    Zagreb, 10 000, Croatia

  • Kinderspital Hämatologie, Zürich

    Zurich, 8032, Switzerland

  • MH Eü. Központ -Orszagos Haemophilia Kozpont

    Budapest, H-1134, Hungary

  • North Estonia Medical Centre Foundation

    Tallinn, 13419, Estonia

  • Ospedale San Bortolo

    Vicenza, 36100, Italy

  • PeK - University Children's Hospital, Department of haematology

    Ljubljana, 1000, Slovenia

  • Policlinico Umberto I Sezione Ematologia

    Roma, 00161, Italy

  • Republican Panevezys Hospital, Public consultation clinic

    Panevezys, LT-35144, Lithuania

  • Tartu University Hospital Haematology Clinic

    Tartu, 50406, Estonia

  • ULS São João, E.P.E.

    Porto, 4200-319, Portugal

  • UMHAT "Tsaritsa Yoanna-ISUL"

    Sofia, 1527, Bulgaria

  • Unilabs Slovensko, s. r. o.

    Košice, 04011, Slovakia

  • Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie

    Bonn, 53127, Germany

  • Vilnius University hospital Santaros klinikos

    Vilnius, 08661, Lithuania

  • Vilnius University hospital Santaros klinikos

    Vilnius, LT-08661, Lithuania

  • Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain

    Berlin, 10249, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.